LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 23.95 | 21.74 | 1027 | 1354 | 0.7582 | 0.9092 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 25.92 | 21.74 | 1 | 1515 | 0.0007 | -0.3952 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 25.92 | 21.74 | 1201 | 1515 | 0.7924 | 0.9254 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 25.92 | 21.74 | 2 | 1515 | 0.0013 | -0.3227 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 25.92 | 21.74 | 1078 | 1515 | 0.7113 | 0.8918 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.89 | 21.74 | 2 | 1677 | 0.0012 | -0.3165 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.89 | 21.74 | 1258 | 1677 | 0.7502 | 0.9104 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.89 | 21.74 | 2 | 1677 | 0.0012 | -0.3165 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.89 | 21.74 | 1146 | 1677 | 0.6834 | 0.8822 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.86 | 21.74 | 2 | 1887 | 0.0011 | -0.3096 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.86 | 21.74 | 1295 | 1887 | 0.6863 | 0.8864 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.86 | 21.74 | 5 | 1887 | 0.0026 | -0.2041 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.86 | 21.74 | 1235 | 1887 | 0.6545 | 0.8726 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.83 | 21.74 | 1 | 2110 | 0.0005 | -0.3728 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.83 | 21.74 | 1380 | 2110 | 0.6540 | 0.8754 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.83 | 21.74 | 8 | 2110 | 0.0038 | -0.1405 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.83 | 21.74 | 1298 | 2110 | 0.6152 | 0.8581 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.80 | 21.74 | 6 | 2381 | 0.0025 | -0.1731 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.80 | 21.74 | 1458 | 2381 | 0.6122 | 0.8603 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.80 | 21.74 | 12 | 2381 | 0.0050 | -0.0840 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.80 | 21.74 | 1375 | 2381 | 0.5774 | 0.8443 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 35.77 | 21.74 | 7 | 2602 | 0.0027 | -0.1514 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 35.77 | 21.74 | 1552 | 2602 | 0.5963 | 0.8557 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 35.77 | 21.74 | 6 | 2602 | 0.0023 | -0.1701 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 35.77 | 21.74 | 1466 | 2602 | 0.5632 | 0.8404 | MN20160310_N01 | L17 |